Correlation Between Alkermes Plc and Avadel Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Alkermes Plc and Avadel Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alkermes Plc and Avadel Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alkermes Plc and Avadel Pharmaceuticals PLC, you can compare the effects of market volatilities on Alkermes Plc and Avadel Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alkermes Plc with a short position of Avadel Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alkermes Plc and Avadel Pharmaceuticals.
Diversification Opportunities for Alkermes Plc and Avadel Pharmaceuticals
0.13 | Correlation Coefficient |
Average diversification
The 3 months correlation between Alkermes and Avadel is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Alkermes Plc and Avadel Pharmaceuticals PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avadel Pharmaceuticals and Alkermes Plc is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alkermes Plc are associated (or correlated) with Avadel Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avadel Pharmaceuticals has no effect on the direction of Alkermes Plc i.e., Alkermes Plc and Avadel Pharmaceuticals go up and down completely randomly.
Pair Corralation between Alkermes Plc and Avadel Pharmaceuticals
Given the investment horizon of 90 days Alkermes Plc is expected to generate 0.36 times more return on investment than Avadel Pharmaceuticals. However, Alkermes Plc is 2.79 times less risky than Avadel Pharmaceuticals. It trades about 0.2 of its potential returns per unit of risk. Avadel Pharmaceuticals PLC is currently generating about -0.05 per unit of risk. If you would invest 2,653 in Alkermes Plc on August 28, 2024 and sell it today you would earn a total of 283.00 from holding Alkermes Plc or generate 10.67% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Alkermes Plc vs. Avadel Pharmaceuticals PLC
Performance |
| Timeline |
| Alkermes Plc |
| Avadel Pharmaceuticals |
Alkermes Plc and Avadel Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Alkermes Plc and Avadel Pharmaceuticals
The main advantage of trading using opposite Alkermes Plc and Avadel Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alkermes Plc position performs unexpectedly, Avadel Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avadel Pharmaceuticals will offset losses from the drop in Avadel Pharmaceuticals' long position.| Alkermes Plc vs. Intracellular Th | Alkermes Plc vs. Ironwood Pharmaceuticals | Alkermes Plc vs. Pacira BioSciences, | Alkermes Plc vs. ANI Pharmaceuticals |
| Avadel Pharmaceuticals vs. Neurocrine Biosciences | Avadel Pharmaceuticals vs. Ironwood Pharmaceuticals | Avadel Pharmaceuticals vs. Alkermes Plc | Avadel Pharmaceuticals vs. Intracellular Th |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |